来自基因表达和转录因子-基因调节的血液恶性瘤的新兴特征
Daniele Dall'Olio1, Federico Magnani1, Francesco Casadei2
1Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
International journal of molecular sciences
|January 8, 2025
概括
这项研究分析了超过5000个血液恶性瘤样本中的基因调节网络. 它揭示了白血病和淋巴瘤的独特分子模式,确定了新的癌症疗法潜在的药物标.
科学领域:
- 血液学 血液学 血液学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 血液性恶性瘤 (HM) 是各种癌症,需要先进的分子表征.
- 识别新型分子签名对于开发新的药物解决方案和临床应用至关重要.
研究的目的:
- 探索转录因子 (TF) 相互作用及其在13种血液性恶性瘤中的生物学途径影响.
- 为了确定潜在的药物点,并提高对HM病理生理学的理解.
主要方法:
- 分析了来自5000多名受试者的公开可用的微阵列数据.
- 基因调节网络 (GRNs) 的估计使用PANDA.
- 层次聚类,网络分析和基因组丰富分析 (GSEA).
主要成果:
- 在白血病和淋巴瘤之间观察到明显的集群模式,具有独特的基因和TF表达特征.
- 确定57个显著丰富的KEGG路径,在HMs中共同和独特.
- 识别潜在的毒品目标,突出了TF的作用,如CEPB和NFE2L1.1.
结论:
- 这项研究增强了对HMS分子格局的理解.
- 这些发现表明了针对性治疗策略的新途径.
- 激励使用监管网络进行胰腺癌研究.
更多相关视频
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
6.6K
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.1K
相关概念视频
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Transcription Factors
75.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.6K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
